Enzo Biochem Inc Cash Flow Conversion Efficiency
Enzo Biochem Inc cash flow conversion efficiency. Based on the latest financial reports, Enzo Biochem Inc (ENZ) has a cash flow conversion efficiency ratio of -0.074x as of April 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.22 Million) by net assets ($43.40 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Enzo Biochem Inc (1989–2024)
Cash flow conversion efficiency of Enzo Biochem Inc from 1989 to 2024. This chart illustrates how Enzo Biochem Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Enzo Biochem Inc for real-time trading data and today's change.
Enzo Biochem Inc Cash Flow Conversion Ratio Explained
Enzo Biochem Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Enzo Biochem Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Enzo Biochem Inc ranked by their cash flow conversion efficiency. Also see ENZ stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Genenta Science SpA ADR
NASDAQ:GNTA
|
-0.077x |
|
Raytech Holding Limited Ordinary Shares
NASDAQ:RAY
|
-0.125x |
|
Fuji Finance Indonesia Tbk PT
JK:FUJI
|
0.122x |
|
Carlin Gold Corporation
V:CGD
|
-0.013x |
|
BR.SCH.ED.HLD.SP.ADR CL.A
F:BSK0
|
N/A |
|
MOUNTAIN VALLEY MD HLDGS
F:20MP
|
N/A |
|
Murano Global Investments PLC Ordinary Shares
NASDAQ:MRNO
|
0.005x |
|
Safeture AB
ST:SFTR
|
0.096x |
Annual Cash Flow Conversion Efficiency for Enzo Biochem Inc (1989–2024)
The table below shows the annual cash flow conversion efficiency of Enzo Biochem Inc from 1989 to 2024. Review ENZ free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-07-31 | $56.11 Million | $-26.26 Million | -0.468x | +0.70% |
| 2023-07-31 | $78.46 Million | $-36.98 Million | -0.471x | -54.71% |
| 2022-07-31 | $54.46 Million | $-16.59 Million | -0.305x | -5498.55% |
| 2021-07-31 | $68.59 Million | $387.00K | 0.006x | +101.92% |
| 2020-07-31 | $58.38 Million | $-17.18 Million | -0.294x | -626.72% |
| 2019-07-31 | $86.03 Million | $4.81 Million | 0.056x | +265.70% |
| 2018-07-31 | $81.12 Million | $-2.73 Million | -0.034x | -1361.62% |
| 2017-07-31 | $88.87 Million | $-205.00K | -0.002x | -100.39% |
| 2016-07-31 | $89.55 Million | $53.13 Million | 0.593x | +783.11% |
| 2015-07-31 | $42.61 Million | $-3.70 Million | -0.087x | -89.09% |
| 2014-07-31 | $36.95 Million | $-1.70 Million | -0.046x | +84.35% |
| 2013-07-31 | $34.13 Million | $-10.02 Million | -0.293x | -141.27% |
| 2012-07-31 | $49.10 Million | $-5.97 Million | -0.122x | -29.60% |
| 2011-07-31 | $88.72 Million | $-8.33 Million | -0.094x | +32.37% |
| 2010-07-31 | $97.02 Million | $-13.46 Million | -0.139x | -41.21% |
| 2009-07-31 | $116.78 Million | $-11.48 Million | -0.098x | -58.70% |
| 2008-07-31 | $138.29 Million | $-8.56 Million | -0.062x | -133.33% |
| 2007-07-31 | $141.89 Million | $-3.77 Million | -0.027x | +74.94% |
| 2006-07-31 | $95.59 Million | $-10.12 Million | -0.106x | -189.40% |
| 2005-07-31 | $108.27 Million | $12.83 Million | 0.118x | +321.11% |
| 2004-07-31 | $104.17 Million | $-5.58 Million | -0.054x | -148.36% |
| 2003-07-31 | $109.38 Million | $12.12 Million | 0.111x | +21.42% |
| 2002-07-31 | $104.73 Million | $9.56 Million | 0.091x | +11.29% |
| 2001-07-31 | $97.52 Million | $8.00 Million | 0.082x | +44.96% |
| 2000-07-31 | $87.18 Million | $4.93 Million | 0.057x | -61.47% |
| 1999-07-31 | $75.60 Million | $11.10 Million | 0.147x | +21.71% |
| 1998-07-31 | $68.80 Million | $8.30 Million | 0.121x | +0.27% |
| 1997-07-31 | $64.00 Million | $7.70 Million | 0.120x | +9.07% |
| 1996-07-31 | $55.30 Million | $6.10 Million | 0.110x | -25.94% |
| 1995-07-31 | $61.10 Million | $9.10 Million | 0.149x | +338.30% |
| 1994-07-31 | $51.20 Million | $-3.20 Million | -0.063x | -352.34% |
| 1993-07-31 | $32.30 Million | $800.00K | 0.025x | -61.08% |
| 1992-07-31 | $33.00 Million | $2.10 Million | 0.064x | +103.04% |
| 1991-07-31 | $1.10 Million | $-2.30 Million | -2.091x | -420.68% |
| 1990-07-31 | $12.70 Million | $-5.10 Million | -0.402x | -29.02% |
| 1989-07-31 | $15.10 Million | $-4.70 Million | -0.311x | -- |
About Enzo Biochem Inc
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development pro… Read more